| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.093 | 0.05 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.05 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.063 | 0.05 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.058 | 0.05 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.064 | 0.05 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | -0.08 | 0.06 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.085 | 0.06 |